ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, H. K.
Right arrow Articles by Kang, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, H. K.
Right arrow Articles by Kang, C. S.
Annals of Clinical & Laboratory Science 34:83-86 (2004)
© 2004 Association of Clinical Scientists

Evaluation of Vitek System for Susceptibility Testing of Enterococcus faecium Isolates

Hae Kyung Lee, Yeon-Joon Park, Hi Jeong Kwon, Eun Jung Lee, Byung Kee Kim and Chang Suk Kang
Department of Clinical Pathology, College of Medicine, Catholic University, Seoul, Korea

Address correspondence to Yeon-Joon Park, M.D., Department of Clinical Pathology, Kangnam St. Mary’s Hospital, 505 Banpo-dong, Seocho-ku, Seoul 137-040, Korea; tel 82 2 590 1604; fax 82 2 592 4190; e-mail yipk{at}catholic.ac.kr.

Although imipenem is not a first-line drug for treating enterococcal infection, it could well become a useful drug for treating mixed infections that include enterococci. However, there is no NCCLS guideline for susceptibility testing of imipenem versus enterococci. Moreover, there are no statements to indicate that in vitro susceptibility results for other antimicrobial agents can be used to predict the in vitro activity of imipenem against enterococci. In this study, 52 Enterococcus faecium isolates were collected from patients hospitalized at Kangnam St. Mary’s Hospital between March 2002 and December 2002. The sources of the isolates were mainly urine specimens and wounds. For ampicillin, the "major" and "very major" error rates observed with the Vitek system were 0% and 2.0%, respectively. For penicillin, the major and very major error rates observed with the Vitek system were both 0%. For imipenem, the major and very major error rates observed with the Vitek system were 0% and 36.5%, respectively. The MICs of ampicillin and penicillin obtained using the Vitek system were reliable, but that of imipenem was unreliable. In the 52 E. faecium isolates, the in vitro activity of penicillin and ampicillin versus enterococci accurately predicted that of imipenem. Therefore, the MIC of imipenem obtained with the Vitek system must be retested by the agar dilution method, when it disagrees with those of penicillin and ampicillin.

Keywords: imipenem, Enterococcus faecium, Vitek system, ampicillin, penicillin






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association of Clinical Scientists.